Ziveria®: Dr. Abidi Pharmaceuticals’ Novel Solution for the Treatment of Allergic Diseases
Dr. Abidi Pharmaceuticals has manufactured and launched Bilastine under the brand name Ziveria® to control the symptoms of allergic rhinitis...
Dr. Abidi Pharmaceuticals has manufactured and launched Bilastine under the brand name Ziveria® to control the symptoms of allergic rhinitis...
Dr. Abidi Pharmaceuticals has unveiled Repiva® as a novel and effective solution for the acute treatment of migraine attacks, offering...
For the first time, Dr. Abidi Pharmaceuticals has introduced the innovative drug Finerenone, under the brand name Miqlon®, to the...
In October 2025, on the eve of Dr. Abidi Pharmaceuticals' 80th anniversary, a team of neurologists, accompanied by colleagues from...
Based on the decision of the Scientific Committee of the Abidi Scientific Awards, research works and articles in the fields...
Exactly 30 years ago, the global medical landscape was revolutionized by the introduction of the first Proton Pump Inhibitor (PPI),...
The 10th anniversary of the introduction of Ropixon® was grandly commemorated on Thursday, April 16 (Farvardin 28), at the Espinas...
The 3rd edition of the Dr. Abidi Scientific Award was successfully held, bringing together esteemed physicians, pharmaceutical industry leaders, and...
The Conference on Pathways to Scientific Authority was held to explore key challenges in this domain and honor 300 distinguished...
Dr. Abidi Pharmaceuticals (PJSC) successfully achieved the first rank in the pharmaceutical industry and the ninth rank in the overall...
Ferrofort, the inaugural product line in Dr. Abidi Pharmaceuticals' supplement division, was launched a decade ago with a primary mission:...
The Diabetes Masterclass series stands as a crowning achievement of Dr. Abidi Pharmaceuticals in advancing diabetes management nationwide. Designed exclusively...
© 2026 Dr. Abidi Pharmaceuticals. All rights reserved.